immune system
• spleen mass is significantly increased relative to C3-null, Faslpr or single Faslpr mutants at 17 weeks of age
|
• lymph node mass is increased relative to C3-null, Faslpr or single Faslpr mutants at 10 and 13 weeks of age
|
• frequency of antibody-secreting cells (ASCs) or antibody-forming cells (AFCs) is significantly increased in spleen, bone marrow, and lymph nodes compared to C3-deficient Fas mutants or single Faslpr mutants
|
• titers of serum ANA are significantly increased at 10 and 17 weeks, compared to single-deficient mice
|
• anti-dsDNA titers are elevated significantly relative to C4, Fas double mutants
|
hematopoietic system
• spleen mass is significantly increased relative to C3-null, Faslpr or single Faslpr mutants at 17 weeks of age
|
renal/urinary system
• increased IgG deposition relative to C3/Fas mutants is observed in kidney sections; deposition is similar to C4/Fas mutants
|
• more severe glomerular abnormalities are observed relative to C3/Fas mutants, and pathology is similar to that of C4/Fas double mutants
|
growth/size/body
• spleen mass is significantly increased relative to C3-null, Faslpr or single Faslpr mutants at 17 weeks of age
|